Teijin Pharma To Start Oxygen Enricher Home Rental Service
This article was originally published in PharmAsia News
Tokyo based Teijin Pharma will offer an oxygen enricher rental service targeting patients requiring oxygen therapy at home. Circulating as many as three liters of oxygen per minute, Hisanso 3R is also able to automatically humidify enriched oxygen, and thus allows patients to use the device themselves. The device also cuts electricity consumption by 40 percent because it adjusts its speed according to oxygen density. Launched this month, Teijin estimates 8,500 such devices will be ordered by the end of 2009. (Click here for more - Japanese language
You may also be interested in...
An EU guideline on the methodological aspects of pharmacoepidemiology has been updated to promote collaboration by researchers on high-quality, multi-centre observational studies in the context of COVID-19.
While Novartis is continuing to provide hydroxychloroquine for ongoing investigator-initiated trials and support for study of a potential vaccine, it has decided to stop sponsoring hydroxychloroquine clinical trials. Meanwhile, Natco has announced donations of chloroquine phosphate for clinical trials, while Centrient and Beximco have provided PPE for healthcare workers.
New chief medical officers take up positions at Abeona Therapeutics, Akcea Therapeutics and Oncologie, while there are new CFOs at Affimed, NGM Biopharmaceuticals, Phathom Pharmaceuticals, Oncologie and Syndax Pharmaceuticals.